Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
8 min read
CD180 Biologics Sequence Review Report 2026: CD180 antigen Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CD180 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL7 Biologics Sequence Review Report 2026: C-C motif chemokine 7 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL7 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL5 Biologics Sequence Review Report 2026: C-C motif chemokine 5 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL5 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL22 Biologics Sequence Review Report 2026: C-C motif chemokine 22 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL22 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL3 Biologics Sequence Review Report 2026: C-C motif chemokine 3 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL26 Biologics Sequence Review Report 2026: C-C motif chemokine 26 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL26 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL19 Biologics Sequence Review Report 2026: C-C motif chemokine 19 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL19 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL20 Biologics Sequence Review Report 2026: C-C motif chemokine 20 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL20 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL2 Biologics Sequence Review Report 2026: C-C motif chemokine 2 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL18 Biologics Sequence Review Report 2026: C-C motif chemokine 18 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL18 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL14 Biologics Sequence Review Report 2026: C-C motif chemokine 14 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
CCL1 Biologics Sequence Review Report 2026: C-C motif chemokine 1 Similarity and Patent-Risk Signals
7 August 2026
A Biology Modality MCP review of CCL1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
6
7
8
9
10
>>
1503
>